https://www.marketscreener.com/quote/stock/IMMUTEP-LIMITED-38892320/news/Immutep-Receives-Constructive-Regulatory-Feedback-on-TACTI-004-Registrational-Trial-in-Metastatic-45612757/?utm_source=telegram&utm_medium=social&utm_campaign=share